AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
-23.09%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$2.14B
AUM Growth
-$1.36B
(-39%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-16.9%
Top 10 Holdings %
Top 10 Hldgs %
86.13%
Holding
660
New
98
Increased
125
Reduced
164
Closed
126
Top Buys
| 1 |
Mastercard
MA
|
$194M |
| 2 |
Visa
V
|
$193M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
$165M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$157M |
| 5 |
Centene
CNC
|
$69.1M |
Top Sells
| 1 |
iShares MSCI South Korea ETF
EWY
|
$200M |
| 2 |
Check Point Software Technologies
CHKP
|
$196M |
| 3 |
Cisco
CSCO
|
$181M |
| 4 |
Fortinet
FTNT
|
$101M |
| 5 |
Nice
NICE
|
$98.9M |
Sector Composition
| 1 | Financials | 29.15% |
| 2 | Technology | 17.39% |
| 3 | Consumer Discretionary | 7.74% |
| 4 | Industrials | 7.59% |
| 5 | Healthcare | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
251
DELISTED
LHC Group LLC
LHCG
| $15K | ﹤0.01% |
109
+3
| +3% | +$413 |
|
252
CACI
CACI
$10.4B
| $14K | ﹤0.01% |
66
-7
| -10% | -$1.49K |
|
253
Chemed
CHE
$6.79B
| $14K | ﹤0.01% |
32
| – | – |
|
|
EFC
254
Ellington Financial
EFC
$1.38B
| $14K | ﹤0.01% |
2,395
+953
| +66% | +$5.57K |
|
255
Entegris
ENTG
$12.4B
| $14K | ﹤0.01% |
+303
| New | +$14K |
|
256
ESCO Technologies
ESE
$5.23B
| $14K | ﹤0.01% |
+185
| New | +$14K |
|
257
Edwards Lifesciences
EW
$47.5B
| $14K | ﹤0.01% |
210
-5,856
| -97% | -$390K |
|
258
Synaptics
SYNA
$2.7B
| $14K | ﹤0.01% |
+234
| New | +$14K |
|
259
TransDigm Group
TDG
$71.6B
| $14K | ﹤0.01% |
46
+45
| +4,500% | +$13.7K |
|
|
NATI
260
DELISTED
National Instruments Corp
NATI
| $14K | ﹤0.01% |
+416
| New | +$14K |
|
261
Baxter International
BAX
$12.5B
| $13K | ﹤0.01% |
163
+159
| +3,975% | +$12.7K |
|
262
BioMarin Pharmaceuticals
BMRN
$11.1B
| $13K | ﹤0.01% |
153
+145
| +1,813% | +$12.3K |
|
263
Calix
CALX
$3.96B
| $13K | ﹤0.01% |
+1,861
| New | +$13K |
|
264
CVS Health
CVS
$93.6B
| $13K | ﹤0.01% |
216
-80
| -27% | -$4.82K |
|
265
Danaher
DHR
$143B
| $13K | ﹤0.01% |
+105
| New | +$13K |
|
266
Dolby
DLB
$6.96B
| $13K | ﹤0.01% |
+244
| New | +$13K |
|
267
Globus Medical
GMED
$8.18B
| $13K | ﹤0.01% |
310
-242
| -44% | -$10.1K |
|
|
GPMT
268
Granite Point Mortgage Trust
GPMT
$143M
| $13K | ﹤0.01% |
2,521
+1,088
| +76% | +$5.61K |
|
269
Idexx Laboratories
IDXX
$51.4B
| $13K | ﹤0.01% |
54
-70
| -56% | -$16.9K |
|
270
Mettler-Toledo International
MTD
$26.9B
| $13K | ﹤0.01% |
+19
| New | +$13K |
|
271
Pegasystems
PEGA
$9.5B
| $13K | ﹤0.01% |
376
-78
| -17% | -$2.7K |
|
272
Penumbra
PEN
$11B
| $13K | ﹤0.01% |
79
-2
| -2% | -$329 |
|
273
Varonis Systems
VRNS
$6.28B
| $13K | ﹤0.01% |
+618
| New | +$13K |
|
274
Agilent Technologies
A
$36.5B
| $12K | ﹤0.01% |
+173
| New | +$12K |
|
275
Addus HomeCare
ADUS
$2.08B
| $12K | ﹤0.01% |
182
+33
| +22% | +$2.18K |
|